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This article presents data related to our another article entitled,
Genotyping and differential expression analysis of inﬂamma-
some genes in sporadic malignant melanoma reveal novel
contribution of CARD8, IL1B and IL18 in melanoma suscept-
ibility and progression (W.C. Silva, T.M. Oshiro, D.C. Sá, D.D.G.S.
Franco, C. Festa Neto, A. Pontillo, 2016) [2]. Data presented here
refers to the distribution of selected inﬂammasome SNPs in a
Brazilian case/control cohort. We have identiﬁed 4 inﬂammasome
related Single Nucleotide Polymorphisms (SNPs) for CARD8
(rs6509365); IL1B (rs1143643) and IL18 (rs5744256 and
rs1834481) related to melanoma susceptibility/protection. This
data can serve as a potential prognostic marker in sporadic
malignant melanoma.
& 2017 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.cancergen.2016.09.004
(W.C. da Silva).
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ore speciﬁc
subject areaImmunogeneticsype of data Tables, ﬁgures
ow data was
acquiredABI Prism 7300 Real Time PCR equipment (Applied Biosystems, Thermoscientiﬁc,
USA), SDS 2.3 software (Applied Biosystems, Thermoscientiﬁc, USA), R software
(www.r-project.org), Haploview softwareata format Raw, analyzed
xperimental
factorsDetermination of clinical data of patients, extraction of DNA from buffy coat and
genetic polymorphism parametersxperimental
featuresAnalysis of polymorphism in inﬂammasome genes in sporadic malignant mela-
noma patients and healthy controlsata source
locationSao Paulo, Brazilata accessibility The data is available with this articleD
Value of the data
 Presence or absence of a particular polymorphism in inﬂammasome genes can drive an individual´s
susceptibility to melanoma.
 This dataset provides some selected inﬂammasome related SNPs’ frequencies in a Brazilian case/
control melanoma cohort and its association with clinical outcomes.
 Comparison of this dataset with other cohort dataset can help to elucidate the contribution of
inﬂammasome genes in the development of and progression to sporadic malignant melanoma.1. Data
A Brazilian case/control SMM cohort was studied concerning frequencies of selected inﬂamma-
some SNPs in NLRP1, NLRP3, CARD8, IL1B and IL18 genes and minor allele frequencies (MAF) with
respective Hardy–Weinberg p-values were calculated.
Case/control analysis were performed and distribution of alleles for each selected SNP, as well as
Odd Ratios (OR), haplotypes, Linkage disequilibrium analysis were determined.rium results for single-nucleotide polymorphisms examined in case/control study. Haploview plot
Table 1
SNPs frequencies in case/control cohort. Minor allele frequencies (MAF) with respective Hardy–Weinberg p-values (HW p)
for studied SNPs are reported in case (SMM) and controls (HC). Hapmap project MAF (or 1000 Genome MAF where indicated)
for Caucasian and African population are included. MAF for SNPs studied by Verma et al., 2012a [1] are also included with
respective p-value for comparisons with SNPs frequencies in studied Brazilian cohorta.
Gene SNP ID Allele SMM HW p HC HW p CEU YRI SMM (Verma et al. [1]) HC (Verma et al. [1])
NLRP1 rs12150220 T 0.44 0.071 0.46 0.079 0.46 0.02 0.52 (0.020) 0.20 (o2exp-16)
rs2670660 G 0.51 0.180 0.46 0.485 0.35n 0.32n
rs11651270 C 0.50 0.059 0.41 0.216 0.47 0.50
NLRP3 rs35829419 A 0.04 1.0 0.04 1.0 0.06 na 0.08 (4.2exp-8) 0.06 (1.0exp-6)
rs10754558 G 0.41 0.878 0.38 0.070 0.36 0.23
CARD8 rs2043211 T 0.29 0.203 0.38 0.855 0.27 0.16 0.34 (0.524) 0.36 (0.026)
rs6509365 G 0.25 0.157 0.40 0.373 0.28 0.32
IL1B rs1143643 T 0.40 1.0 0.37 0.804 0.39 0.15
IL18 rs5744256 G 0.18 0.803 0.20 0.177 0.22 na
rs1834481 G 0.17 0.628 0.20 0.103 0.23 na
a data from 1000 Genome.
Table 2
Association results for inﬂammasome polymorphisms in sporadic malignant melanoma. Genotype frequencies are
reported as well as unadjusted p-values (p), p-values adjusted for age, sex and ethnicity (padj) and respective Odds Ratio (OR)
and 95% conﬁdence intervals (95% CI). Statistically signiﬁcant results (po0.005) are indicated in bold characters. SMM:
sporadic malignant melanoma; HC: healthy controls; Ref: reference genotype.
Gene SNP ID Genotypes SMM (n¼198) HC (n¼142) p OR (95%IC) padj OR (95%IC)
NLRP1 rs12150220 T/T 0.23 0.25 0.887 0.87 (0.48–1.58) 0.673 0.86 (0.43–1.69)
A/T 0.42 0.42 0.98 (0.58–1.64) 1.15 (0.64–2.08)
A/A 0.35 0.33 Ref Ref
rs2670660 G/G 0.28 0.19 0.145 1.54 (0.81–2.93) 0.166 1.69 (0.81–3.54)
A/G 0.45 0.53 0.87 (0.51–1.49) 0.91 (0.49–1.69)
A/A 0.27 0.28 Ref Ref
rs11651270 C/C 0.28 0.19 0.155 1.84 (0.98–3.44) 0.132 1.97 (0.97–3.99)
T/C 0.43 0.43 1.25 (0.73–2.12) 1.11 (0.61–2.01)
T/T 0.29 0.37 Ref Ref
NLRP3 rs35829419 A/A 0 0 0.911 – 0.810 –
C/A 0.07 0.07 1.05 (0.44 -2.54) 1.13 (0.42–3.02)
C/C 0.93 0.93 Ref Ref
rs10754558 G/G 0.17 0.18 0.310 1.14 (0.60–2.16) 0.467 1.20 (0.58–2.46)
C/G 0.48 0.40 1.46 (0.89- 2.40) 1.42 (0.81–2.48)
C/C 0.35 0.42 Ref Ref
CARD8 rs2043211 T/T 0.06 0.13 0.043 0.37 (0.16–0.83) 0.102 0.39 (0.15–0.98)
A/T 0.45 0.49 0.73 (0.46–1.18) 0.69 (0.40–1.19)
A/A 0.49 0.38 Ref Ref
rs6509365 G/G 0.08 0.18 3.1 exp-4 0.28 (0.13–0.58) 1.7 exp-4 0.35 (0.15–0.80)
A/G 0.33 0.44 0.48 (0.29–0.78) 0.41 (0.24–0.72)
A/A 0.59 0.38 Ref Ref
IL1B rs1143643 T/T 0.16 0.12 0.700 1.45 (0.59–3.56) 0.581 1.76 (0.56–5.53)
C/T 0.48 0.49 1.06 (0.58–1.95) 1.02 (0.46–2.27)
C/C 0.36 0.39 Ref Ref
IL18 rs5744256 G/G 0.03 0.06 0.589 0.58 (0.19–1.72) 0.235 0.39 (0.12–1.29)
A/G 0.29 0.28 1.03 (0.62 -1.70) 0.77 (0.44–1.34)
A/A 0.67 0.66 Ref Ref
rs1834481 G/G 0.05 0.07 0.755 0.64 (0.17 -2.36) 0.244 0.40 (0.09–1.86)
C/G 0.23 0.25 0.87 (0.43–1.74) 0.58 (0.27–1.28)
C/C 0.73 0.69 Ref Ref
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Table 3
Association results for IL18rs5744256-rs1834481 haplotypes. Frequencies for SMM patients (case) and healthy donors
(control) as well as p-values are reported for resulted rs5744256-rs1834481 haplotypes. Only haplotypes with frequency
40.05 are included in GLM analysis. SMM: sporadic malignant melanoma; HC: healthy controls.
Haplotypes Rs5744256-rs1834481 Case/Control Frequencies p padj
C-A 0.79/0.80 ref ref
G-G 0.17/0.19 0.8647 0.8512
rare 0.04/0.01 0.1663 0.1381
Table 4
Association results for inﬂammasome polymorphisms in melanoma patients stratiﬁed for histological tumor type. Gene
symbol, polymorphism identiﬁcation number (SNP ID), p-values adjusted for sex, age and ethnicity are reported for three
comparisons: superﬁcial spreading melanoma (SSM) versus nodular melanoma (NM), SSM versus lentigo malignant melanoma
(LMM) and SSM versus melanoma “in situ”. Statistically signiﬁcant values are indicated in bold characters. nd: not determined.
Gene SNP ID SSM (n¼77)/ NM
(n¼30)
SSM (n¼77)/
LMM (n¼21)
SSM (n¼77)/
in situ(n¼29)
Dominant model
of inheritance
Recessive model
of inheritance
Recessive model
of inheritance
NLRP1 rs12150220 0.018 0.109 0.639
rs2670660 0.229 0.475 0.820
rs11651270 0.003 0.060 0.08
NLRP3 rs35829419 nd nd nd
rs10754558 0.303 0.020 0.952
CARD8 rs2043211 0.005 0.108 0.792
rs6509365 0.040 0.983 0.600
IL1B rs1143643 0.815 0.904 0.020
IL18 rs5744256 0.903 0.937 0.050
rs1834481 0.176 0.946 0.030
Table 5
Association results for inﬂammasome polymorphisms in melanoma patients according to invasiveness and skin type.
Gene symbol, polymorphism identiﬁcation number (SNP ID), multivariate analysis p-values adjusted for sex, age at diagnosis
and ethnicity are reported for SMM patients according to invasiveness (Breslow index), with less invasive (o2 mm) or more
invasive (Z2 mm) tumors; or with sun-sensitive or less sun-sensitive skin types. Statistically signiﬁcant values are indicated in
bold characters. nd: not determined.
Gene SNP ID Tumor invasiveness Skin type
Z 2 mm (n¼30)/
o2 mm(n¼133)
Sun-sensitive (n¼94)/Less
sun-sensitive (n¼57)
NLRP1 rs12150220 0.690 0.880
rs2670660 0.645 0.950
rs11651270 0.616 0.836
NLRP3 rs35829419 nd nd
rs10754558 0.537 0.986
CARD8 rs2043211 0.256 0.692
rs6509365 0.409 0.624
IL1B rs1143643 0.004 0.978
IL18 rs5744256 0.970 0.003
rs1834481 0.455 0.027
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represented (Fig. 1).2. Experimental design, materials and methods
Refer to the associated article [2] for detailed methods (Table 1–5).Acknowledgements
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